Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
46.89
+0.01 (0.03%)
At close: Jun 20, 2025
12.82%
Market Cap 69.75B
Revenue (ttm) 36.87B
Net Income (ttm) 4.19B
Shares Out n/a
EPS (ttm) 2.07
PE Ratio 16.63
Forward PE 7.20
Dividend 1.91 (4.07%)
Ex-Dividend Date Apr 4, 2025
Volume 6,864
Average Volume 15,603
Open 47.15
Previous Close 46.88
Day's Range 46.72 - 47.39
52-Week Range 38.27 - 63.17
Beta 0.39
RSI 41.34
Earnings Date Jul 31, 2025

About LON:0R1F

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.